OIP — The Opportunity Intelligence PlatformOIP / Government Intelligence
Preparing the stored Government Intelligence discovery view.
OIP / Government Intelligence / Opportunity detail
Source: Stored live-derived Government dataStephanie Bogan Grantor
OIP derived this review page from stored live-derived Government Intelligence source records. The official source and issuing agency remain authoritative.
Opportunity Intelligence Platform is an independent service and is not affiliated with or endorsed by the U.S. Government. Official notices, amendments, attachments, eligibility requirements, funding terms, and deadlines remain under source control.
OIP scores and explanations are informational and do not guarantee eligibility, suitability, compliance, contract award, or financial outcome.
Others (see text field entitled "Additional Information on Eligibility" for clarification)
4 warning(s) require review.
Objective score, derived by OIP
Publication decision: Publish with warning
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional) -- a Grant (Grant) issued by Stephanie Bogan Grantor.
Objective Government score 69 for grants-gov-360007, computed from source evidence and Government scoring configuration.
No dimensions were marked insufficient_evidence or not_applicable for this opportunity.
10 evidence record(s) support this pipeline result.
Next action: Review the official Grants.gov opportunity and follow the listed application package instructions.
95/100 · Ok
evidence_quality scored from source evidence and Government scoring guidance (value kind deterministic_calculation, confidence rank 0).
90/100 · Ok
confidence scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
88/100 · Ok
potential_value scored from source evidence and Government scoring guidance (value kind deterministic_calculation, confidence rank 0).
62/100 · Ok
urgency scored from source evidence and Government scoring guidance (value kind deterministic_calculation, confidence rank 0).
56/100 · Ok
difficulty scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
62/100 · Ok
time_required scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
48/100 · Ok
capital_required scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
52/100 · Ok
risk scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
$.detail.opportunityTitle · Field Mapping · 98/100 confidence
360007 / RFA-FD-25-017
$.detail.id · Field Mapping · 99/100 confidence
Stephanie Bogan Grantor
$.detail.synopsis.agencyName · Field Mapping · 97/100 confidence
Grant
$.detail.synopsis.fundingInstruments · Field Mapping · 96/100 confidence
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
$.detail.synopsis.synopsisDesc · Field Mapping · 94/100 confidence
2025-07-11T04:00:00.000Z
$.detail.synopsis.postingDate · Field Mapping · 96/100 confidence
2028-02-08T00:00:00.000Z
$.searchHit.closeDate · Field Mapping · 92/100 confidence
Applicant types: Others (see text field entitled "Additional Information on Eligibility" for clarification)
$.detail.synopsis.applicantTypes · Field Mapping · 94/100 confidence
600000.00
$.detail.synopsis.awardCeiling · Field Mapping · 92/100 confidence
2025-07-11T18:51:21.000Z
$.detail.synopsis.lastUpdatedDate · Field Mapping · 88/100 confidence
Official source materials control eligibility, deadlines, amendments, attachments, and funding terms.
Open official source68/100 · Ok
novelty scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).